Latest News
Oriole Resources awarded five new licences in Cameroon
West Africa-focussed exploration company Oriole Resources said on Wednesday that it has, through its 90%-owned subsidiary Oriole Cameroon, been awarded five new licences in central Cameroon.
Scancell ends clinical development partnership with Cancer Research UK
Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.
Hiring by US private employers increases in January
US private employers hired more workers in January than in the previous month despite new Covid-19 infections continuing to soar across the country.
Air cargo suffers worst year since records began
Demand for air cargo fell suffered its sharpest fall in 2020 since records began as capacity plunged by more than a fifth in the Covid-19 crisis.
Deutsche Bank raises target price on Polypipe
Analysts at Deutsche Bank raised their target price on Polypipe from 561. 0p to 602. 0p on Wednesday after the group raised 2020 underlying earnings guidance once again.
Jazz Pharmaceuticals to buy GW Pharmaceuticals for $7.2bn
Jazz Pharmaceuticals has agreed to buy GW Pharmaceuticals for $7. 2bn.
Asia report: Most markets higher, China services growth slows
Markets in Asia closed mostly higher on Wednesday, as investors digested the latest data on China’s services sector.
4D Pharma makes progress with MRx0518 development programme
Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-oncology single strain ‘live biotherapeutic’ candidate MRx0518 on Wednesday.
Hummingbird Resources pleased with fourth quarter performance
Hummingbird Resources updated the market on operations in its fourth quarter on Wednesday, recording a net cash positive position of $1. 5m (£1. 1m) at period end on 31 December.
Wednesday broker round-up
Unite Group: Barclays downgrades to underweight with a target price of 850p.
Mazda to cut global vehicle output by 34,000 over next two months
Mazda Motor is set to cut its global car output by 34,000 in February and March due to a shortage of chips, sources told Reuters on Wednesday.
Wednesday preview: US ADP report, Vodafone in the spotlight
Investors' attention will shift back towards the US in the middle of the week amid key data releases and company earnings.
GlaxoSmithKline forecasts decline in 2021 earnings, shares slump
Shares of GlaxoSmithKline slumped on Wednesday after the pharmaceuticals giant said it expects 2021 earnings to decline, as it reported growth in revenues and profit for 2020.
SpaceX Starship rocket explodes after test launch
A prototype of SpaceX’s Starship rocket exploded again during a landing attempt after an experimental launch in Texas, on Tuesday.
Eurozone inflation surges in January, beating forecasts
Eurozone inflation rebounded sharply in January, official data showed on Wednesday, beating expectations.
Europe midday: Italy shares rally on hopes 'Super Mario' can form govt
European shares maintained gains for the third straight session as Italian shares outperformed on hopes former European Central Bank chief Mario Draghi would agree to form a unity government.
US pre-open: Stocks slightly higher as earnings continue to pour in
Wall Street futures had stocks opening slightly higher ahead of the bell yet again on Wednesday as major corporate earnings remained firmly in focus.
Redrow interims to be catalyst for shares, JP Morgan says
Redrow’s first-half results will help the company’s shares narrow the gap with the rest of the UK housebuilders, JP Morgan said.
UK admits Brexit port delays more than 'teething problems'
UK government minister Michael Gove admitted that Brexit border delays were more than “teething problems” as he asked the EU for an extension to 2023 of grace periods for full checks on goods traded between Britain and Northern Ireland.
London midday: Stocks pare gains after services data
London stocks had pared gains by midday on Wednesday to trade just a touch higher, as investors weighed up uninspiring services data against optimism over the vaccine rollout and US stimulus.